Vertex Pharmaceuticals Inc
F:VX1
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
V
|
Vertex Pharmaceuticals Inc
F:VX1
|
US |
|
S
|
Safran SA
XMUN:SEJ1
|
FR |
|
S
|
Schneider Electric SE
DUS:SND
|
FR |
|
T
|
TAG Immobilien AG
F:TEG
|
DE |
|
C
|
Constellation Brands Inc
DUS:CB1A
|
US |
|
F
|
Fast Retailing Co Ltd
XBER:FR7
|
JP |
|
H
|
Hyundai Motor Co
XMUN:HYU
|
KR |
|
A
|
Abbott Laboratories
XMUN:ABL
|
US |
|
R
|
Rollins Inc
F:RLS
|
US |
|
B
|
Banco Santander SA
BCBA:STD
|
ES |
|
A
|
Air China Ltd
F:AD2
|
CN |
|
W
|
Westinghouse Air Brake Technologies Corp
XBER:WB2
|
US |
|
H
|
Harmony Gold Mining Company Ltd
SWB:HAM
|
ZA |
|
S
|
Surteco Group SE
DUS:SUR
|
DE |
Wall St Price Targets
VX1 Price Targets Summary
Vertex Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for VX1 is 492.72 EUR with a low forecast of 308.12 EUR and a high forecast of 596.71 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is VX1's stock price target?
Price Target
492.72
EUR
According to Wall Street analysts, the average 1-year price target for VX1 is 492.72 EUR with a low forecast of 308.12 EUR and a high forecast of 596.71 EUR.
What is the Revenue forecast for Vertex Pharmaceuticals Inc?
Projected CAGR
10%
Over the last 13 years, the compound annual growth rate for Revenue has been 17%. The projected CAGR for the next 8 years is 10%.
What is the Gross Profit forecast for Vertex Pharmaceuticals Inc?
Projected CAGR
10%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 17%. The projected CAGR for the next 8 years is 10%.
What is the Operating Income forecast for Vertex Pharmaceuticals Inc?
Projected CAGR
15%
Over the last 13 years, the compound annual growth rate for Operating Income has been 42%. The projected CAGR for the next 8 years is 15%.
What is the Pre-Tax Income forecast for Vertex Pharmaceuticals Inc?
Projected CAGR
21%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 47%. The projected CAGR for the next 3 years is 21%.
What is the Net Income forecast for Vertex Pharmaceuticals Inc?
Projected CAGR
14%
The compound annual growth rate for Net Income over the next 8 years is 14%.
